Dynamic distribution of bone marrow-derived mesenchymal stromal cells and change of pathology after infusing into mdx mice
Authors:
- 1 January 2008
- journal article
- Published by Elsevier in Cytotherapy
- Vol. 10 (3) , 254-264
Abstract
Mesenchymal stromal cells (MSC) are attractive candidates for the treatment of Duchenne muscular dystrophy (DMD) but how the donor MSC distribute in multiple organs and whether the increased dystrophin leads to a change in the pathology of mdx mice is still uncertain. In this research we detected the distribution of MSC and the pathology of mdx mice after MSC infusion. MSC were isolated from rat bone marrow (BM) and expanded in proliferation medium. MSC of the fifth passage were delivered intravenously into irradiated mdx mice. The distribution of MSC labeled by [3H]TdR into a recipient's organs was calculated by radioactivity. The expression of dystrophin was detected at weeks 4, 8, 12 and 16 after MSC transplantation by immunofluorescence staining, RT-PCR and Western blot. Serum creatine kinase (CK) and centrally nucleated fiber (CNF) were also detected to assess the change in pathology. 24–48 h after transplantation, MSC were mainly found in the BM, liver and lung. The radioactivity in these organs decreased, whereas skeletal and myocardial muscle radioactivity increased gradually over time. In accordance with the increased radioactivity in skeletal muscle, the amount of dystrophin-positive myofibers increased. Furthermore, serum CK and CNF decreased slightly, suggesting specific pathophysiologic features of the dystrophic muscle were partially restored. Upon certification of the distribution of transplanted MSC in irradiated mdx mice, we found evidence of myogenic differentiation of MSC in skeletal muscle. This research may help us understand the mechanism of therapy of MSC transplantation.Keywords
This publication has 29 references indexed in Scilit:
- Current treatment of adult Duchenne muscular dystrophyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Widespread Distribution and Muscle Differentiation of Human Fetal Mesenchymal Stem Cells After Intrauterine Transplantation in Dystrophic mdx MouseStem Cells, 2006
- A highly functional mini-dystrophin / GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophyHuman Molecular Genetics, 2006
- Bone Marrow Stromal Cells Generate Muscle Cells and Repair Muscle DegenerationScience, 2005
- Skeletal muscle differentiation potential of human adult bone marrow cellsExperimental Cell Research, 2004
- Dystrophin expression in the mdx mouse restored by stem cell transplantationNature, 1999
- Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophyNeuromuscular Disorders, 1996
- Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5‐azacytidineMuscle & Nerve, 1995
- Muscular Dystrophies—Diseases of the Dystrophin-Glycoprotein ComplexScience, 1995
- The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophyNature, 1991